Active/Pro-Caspase 3 Monoclonal Antibody (CPP32 4-1-18)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0481706
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $429.65
About this award
The University of Virginia awarded contract A207_PO-0481706 to Life Technologies Corporation on September 17, 2026, with a total cumulative value of $429.00. The contract encompasses the procurement of specialized laboratory reagents for research purposes within the Commonwealth of Virginia. The specific deliverable consists of one unit of Active/Pro-Caspase 3 Monoclonal Antibody (CPP32 4-1-18), a protein detection reagent commonly utilized in apoptosis research and cellular analysis applications.
The line item is designated for delivery to Xinhua Zhan at the University of Virginia, with a unit price of $429.65. The contract represents a direct procurement of critical research materials to support the University's scientific operations. As a limited-scope purchase order, the contract specifies a defined scope of work focused on the supply of the identified monoclonal antibody product with no additional services or extended deliverables indicated.
Line items
| Item | Total |
|---|---|
| Active/Pro-Caspase 3 Monoclonal Antibody (CPP32 4-1-18) | $429.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0481706?
Contract A207_PO-0481706 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on September 17, 2026.
How much is contract A207_PO-0481706 worth?
Its cumulative value is $429.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award